HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$2.08
Day range
$2.05 - $2.14
Year range
$1.46 - $3.26
Market cap
308.37M USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 40.64M | 22.42% |
Operating expense | 48.91M | 18.85% |
Net income | -18.98M | -12.75% |
Net profit margin | -46.70 | 7.91% |
Earnings per share | -0.14 | -16.67% |
EBITDA | -11.21M | -9.86% |
Effective tax rate | -1.64% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 87.35M | -8.15% |
Total assets | 336.62M | 4.75% |
Total liabilities | 345.79M | 18.70% |
Total equity | -9.18M | — |
Shares outstanding | 148.26M | — |
Price to book | -34.67 | — |
Return on assets | -10.80% | — |
Return on capital | -14.78% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -18.98M | -12.75% |
Cash from operations | -20.30M | 22.33% |
Cash from investing | -19.65M | 55.32% |
Cash from financing | 35.19M | 4,178.10% |
Net change in cash | -4.76M | 93.30% |
Free cash flow | -31.26M | -732.94% |
About
Founded
2005
Headquarters
Website
Employees
377